MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG

MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG

Objective: to evaluate the symptom- and structure-modifying effect of alflutop versus placebo (PL) in patients with knee osteoarthrosis (OA).Subjects and methods. The trial enrolled 90 patients with knee OA (ACR criteria and Kellgren–Lawrence Stages II–III) and pain on walking ≥ 40 mm on a visual an...

Full description

Bibliographic Details
Main Authors: Lyudmila Ivanovna Alekseeva, E P Sharapova, E A Taskina, N V Chichasova, G R Imametdinova, N A Shostak, N G Pravdyuk, L N Denisov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2013-12-01
Series:Научно-практическая ревматология
Subjects:
knee osteoarthrosis
double-blind randomized placebo-controlled trial
alflutop
placebo
Online Access:https://rsp.mediar-press.net/rsp/article/view/1340

Similar Items

Similar Items